Vitamin-based therapy for breast cancer: Vitamin-E suppresses the expression Sema4c, epithelial-mesenchymal transition and chemotherapeutic resistance via up regulation of its target gene, 27/January/20145, 07.08 am

MiRNA-based therapy for Stroke: MiRNA-30d inhibits cerebral ischemia induced injury via down regulation of its target gene, 27/January/2015, 07.04 am
January 27, 2015
Molecular therapy for Cancer: Aspirin increases the expression of tumor suppressor FBXO11 via down regulation of its target gene, 27/January/2015, 07.14 am
January 27, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Vitamin-based therapy for breast cancer: Vitamin-E suppresses the expression Sema4c, epithelial-mesenchymal transition and chemotherapeutic resistance via up regulation of its target gene, 27/January/20145, 07.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Vitamin-E, by increasing the expression of its target gene, it may suppress the expression Sema4c, epithelial-mesenchymal transition and chemotherapeutic resistance.  Thus, pharmacological formulations encompassing “Vitamin-E or its analogues”  may be used to inhibit the progression of human tumors.

Amount: $ 300

Undisclosed information: How Vitamin-E suppresses the expression of Sema4c

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.